Literature DB >> 16143574

Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing.

Tetsuro Nakazawa1, Arata Nakajima, Koji Shiomi, Hideshige Moriya, Thomas A Einhorn, Masashi Yamazaki.   

Abstract

Recent studies have demonstrated that intermittent administration of parathyroid hormone (PTH) enhances osteogenesis (hard callus formation) and increases mechanical strength in experimental fracture healing. Thus far, however, effects of PTH on chondrogenesis (soft callus formation) during fracture healing have not been fully elucidated. In the present study, we analyzed the underlying molecular mechanism by which exogenous PTH would affect chondrogenesis in a model of experimental fracture healing. Unilateral femoral fractures were produced in 2-month-old Sprague-Dawley rats. Daily subcutaneous injections of 10 microg/kg of recombinant human PTH(1-34) [rhPTH(1-34)] were administered over a 28-day period of fracture healing. Control animals were injected with vehicle solution (normal saline) alone. The results showed that, on day 14 after fracture, cartilage area in the PTH-treated group was significantly increased (1.4-fold) compared with the controls, but this increase was not observed at days 21 and 28. In the early stage of chondrogenesis (days 4-7), cell proliferation, expressed as the rate of proliferating cell nuclear antigen-positive cells, was increased in mesenchymal (chondroprogenitor) cells but not chondrocytes in the PTH-treated group compared with controls. In addition, gene expression of SOX-9 was up-regulated in the PTH-treated group on day 4 (1.4-fold), and this was accompanied by enhanced expression of pro-alpha1 (II) collagen (1.8-fold). After 14 days, there were no significant differences between groups in either cell proliferation or the expression levels of cartilage differentiation-related genes (SOX-9, pro-alpha1 (II) collagen, pro-alpha1 (X) collagen and osteopontin). These results suggest that intermittent treatment with low-dose rhPTH(1-34) induces a larger cartilaginous callus but does not delay chondrocyte differentiation during fracture healing.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16143574     DOI: 10.1016/j.bone.2005.06.013

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  54 in total

1.  Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis.

Authors:  Erik R Sampson; Matthew J Hilton; Ye Tian; Di Chen; Edward M Schwarz; Robert A Mooney; Susan V Bukata; Regis J O'Keefe; Hani Awad; J Edward Puzas; Randy N Rosier; Michael J Zuscik
Journal:  Sci Transl Med       Date:  2011-09-21       Impact factor: 17.956

2.  Delayed short-course treatment with teriparatide (PTH(1-34)) improves femoral allograft healing by enhancing intramembranous bone formation at the graft-host junction.

Authors:  Masahiko Takahata; Edward M Schwarz; Tony Chen; Regis J O'Keefe; Hani A Awad
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

3.  The effect of mesenchymal stem cells delivered via hydrogel-based tissue engineered periosteum on bone allograft healing.

Authors:  Michael D Hoffman; Chao Xie; Xinping Zhang; Danielle S W Benoit
Journal:  Biomaterials       Date:  2013-08-16       Impact factor: 12.479

4.  Teriparatide (human PTH1-34) compensates for impaired fracture healing in COX-2 deficient mice.

Authors:  Kiminori Yukata; Chao Xie; Tian-Fang Li; Matthew L Brown; Tsukasa Kanchiku; Xinping Zhang; Hani A Awad; Edward M Schwarz; Christopher A Beck; Jennifer H Jonason; Regis J O'Keefe
Journal:  Bone       Date:  2018-02-03       Impact factor: 4.398

Review 5.  A perspective: engineering periosteum for structural bone graft healing.

Authors:  Xinping Zhang; Hani A Awad; Regis J O'Keefe; Robert E Guldberg; Edward M Schwarz
Journal:  Clin Orthop Relat Res       Date:  2008-05-29       Impact factor: 4.176

Review 6.  Mechanisms Underlying Normal Fracture Healing and Risk Factors for Delayed Healing.

Authors:  Cheng Cheng; Dolores Shoback
Journal:  Curr Osteoporos Rep       Date:  2019-02       Impact factor: 5.096

7.  Parathyroid hormone (1-34) promotes fracture healing in ovariectomized rats with type 2 diabetes mellitus.

Authors:  G Y Liu; G L Cao; F M Tian; H P Song; L L Yuan; L D Geng; Z Y Zheng; L Zhang
Journal:  Osteoporos Int       Date:  2017-08-14       Impact factor: 4.507

8.  Tensile type of stress fracture neck of femur: role of teriparatide in the process of healing in a high risk patient for impaired healing of fracture.

Authors:  Rajesh Malhotra; Sanjay Meena; Vijay Kumar Digge
Journal:  Clin Cases Miner Bone Metab       Date:  2013-09

9.  Recent advances toward the clinical application of PTH (1-34) in fracture healing.

Authors:  Cara A Cipriano; Paul S Issack; Lisa Shindle; Clément M L Werner; David L Helfet; Joseph M Lane
Journal:  HSS J       Date:  2009-03-17

10.  Effects of low-dose parathyroid hormone on bone mass, turnover, and ectopic osteoinduction in a rat model for chronic alcohol abuse.

Authors:  U T Iwaniec; C H Trevisiol; G F Maddalozzo; C J Rosen; R T Turner
Journal:  Bone       Date:  2008-01-12       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.